Public Profile

Endologix LLC

Endologix LLC, a prominent player in the medical device industry, is headquartered in the United States and focuses on innovative solutions for vascular diseases. Founded in 1992, the company has made significant strides in the development of advanced endovascular technologies, particularly for the treatment of abdominal aortic aneurysms (AAAs). Endologix is renowned for its unique product offerings, including the AFX® Endovascular AAA System and the Ovation® iX Abdominal Stent Graft System, which are designed to enhance patient outcomes through minimally invasive procedures. With a strong presence in North America and expanding operations in Europe, Endologix has established itself as a leader in the vascular intervention market, consistently recognised for its commitment to quality and innovation.

DitchCarbon Score

How does Endologix LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

18

Industry Average

Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

4

Industry Benchmark

Endologix LLC's score of 18 is higher than 66% of the industry. This can give you a sense of how well the company is doing compared to its peers.

66%

Endologix LLC's reported carbon emissions

Endologix LLC, headquartered in the US, currently does not have publicly available carbon emissions data or specific reduction targets. Without concrete figures or commitments, it is unclear how the company is addressing its carbon footprint or contributing to climate action. In the absence of detailed emissions data, it is essential to monitor industry trends and best practices for climate commitments, as many companies are increasingly adopting science-based targets and sustainability initiatives. Endologix's future climate strategies may align with these industry standards, but specific information is not available at this time.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Endologix LLC's primary industry is Medical, precision and optical instruments, watches and clocks (33), which is low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Endologix LLC is headquartered in US, which has a rank of low, indicating low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Endologix LLC is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Similar Organizations

Merit Medical

US
Medical, precision and optical instruments, watches and clocks (33)
Updated 2 days ago

Medtronic, Inc.

US
Health and social work services (85)
Updated 5 days ago
DitchCarbon Score

Vion

NL
Food products nec
Updated 4 minutes ago

Penumbra, Inc.

US
Medical, precision and optical instruments, watches and clocks (33)
Updated 5 days ago

Terumo Medical Corporation

US
Medical, precision and optical instruments, watches and clocks (33)
Updated 2 days ago
DitchCarbon Score

Baxter

US
Health and social work services (85)
Updated 2 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers